BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 38461596)

  • 1. Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis.
    Mey GM; Evonuk KS; Chappell MK; Wolfe LM; Singh R; Batoki JC; Yu M; Peachey NS; Anand-Apte B; Bermel R; Ontaneda D; Nakamura K; Mahajan KR; DeSilva TM
    Acta Neuropathol Commun; 2022 Jun; 10(1):87. PubMed ID: 35706005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual evoked potentials in patients with congenital color vision deficiency.
    Kızıltaş B; Fidancı H
    Int Ophthalmol; 2024 Jun; 44(1):265. PubMed ID: 38913194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7T Magnetic Resonance Imaging Probabilistic Tractography-Based Evidence of Decussation of the Fibers Between the Lateral Geniculate Nucleus and the Primary Visual Area.
    Vilela-Filho O; Freitas ELA; Goulart LC; Lino-Filho AM; Carneiro R; Fernandes-Santos B
    World Neurosurg; 2024 May; ():. PubMed ID: 38823444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis.
    Behbehani R; Ali A; Al-Omairah H; Rousseff RT
    Mult Scler Relat Disord; 2020 Jun; 41():101988. PubMed ID: 32092503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Pattern Reversal and Flash Visual Evoked Potential Latencies With Optical Coherence Tomography Measures in Patients With Optic Neuropathy and Patients With Multiple Sclerosis Without Optic Neuropathy.
    Moussa H; Sawaya RA; Deeb R; El Ayoubi N
    J Clin Neurophysiol; 2022 Nov; 39(7):637-642. PubMed ID: 33555731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Shen T; You Y; Arunachalam S; Fontes A; Liu S; Gupta V; Parratt J; Wang C; Barnett M; Barton J; Chitranshi N; Zhu L; Fraser CL; Graham SL; Klistorner A; Yiannikas C
    Ophthalmology; 2019 Mar; 126(3):445-453. PubMed ID: 30060979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
    Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
    Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.
    Papadopoulou A; Gaetano L; Pfister A; Altermatt A; Tsagkas C; Morency F; Brandt AU; Hardmeier M; Chakravarty MM; Descoteaux M; Kappos L; Sprenger T; Magon S
    Neurology; 2019 May; 92(19):e2240-e2249. PubMed ID: 30971483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus.
    Papadopoulou A; Pfister A; Tsagkas C; Gaetano L; Sellathurai S; D'Souza M; Cerdá-Fuertes N; Gugleta K; Descoteaux M; Chakravarty MM; Fuhr P; Kappos L; Granziera C; Magon S; Sprenger T; Hardmeier M
    Clin Neurophysiol; 2024 May; 161():122-132. PubMed ID: 38461596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afferent visual pathways in multiple sclerosis: a review.
    Graham SL; Klistorner A
    Clin Exp Ophthalmol; 2017 Jan; 45(1):62-72. PubMed ID: 27011293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.
    Silbermann E; Wooliscroft L; Bourdette D
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):49. PubMed ID: 29923130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
    Petzold A; Balcer LJ; Calabresi PA; Costello F; Frohman TC; Frohman EM; Martinez-Lapiscina EH; Green AJ; Kardon R; Outteryck O; Paul F; Schippling S; Vermersch P; Villoslada P; Balk LJ;
    Lancet Neurol; 2017 Oct; 16(10):797-812. PubMed ID: 28920886
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.